{
    "clinical_study": {
        "@rank": "67157", 
        "arm_group": {
            "arm_group_label": "PET/MR", 
            "arm_group_type": "Experimental", 
            "description": "Multi-radiotracer PET/MR will be performed to compare the accuracy of tumor detection in patient with primary prostate cancer"
        }, 
        "brief_summary": {
            "textblock": "To development of clinical assessment technique using multi-radiotracer positron emission\n      tomography/magnetic resonance (PET/MR) in prostate cancer\n\n        -  to establish the optimal imaging technique of PET/MR using multiple radioactive tracers\n           for prostate cancer\n\n        -  to establish the imaging biomarker using PET/MR for clinical assessment of prostate\n           cancer and early detection of recurrent prostate cancer"
        }, 
        "brief_title": "Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Prostate Cancer Recurrent", 
            "Stage II Prostate Carcinoma", 
            "Stage III Prostate Carcinoma"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma", 
                "Prostatic Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "To establish the optimal imaging technique of PET/MR using multiple radioactive tracers for\n      prostate cancer\n\n        -  Recruiting 30 patients with prostate cancer ahead to radical prostatectomy\n\n        -  PET/MR using 18F-choline with dedicated prostate MRI in all patients\n\n        -  PET/MR using 18fluoride(F)-fluorodeoxyglucose(FDG)in all patients after 2-7 days\n\n        -  PET/CT using 18F-FDG in all patient immediate after 18F-FDG PET/MR\n\n        -  outcome assessment: comparison of scan time, image quality, tumor detection rate,\n           standardized uptake values of lesions\n\n        -  establishing optimal imaging technique for prostate PET/MR\n\n      To establish the imaging biomarker using PET/MR for clinical assessment of prostate cancer\n\n        -  comparison of findings on PET/MR, MRI and PET/CT with pathological mapping after\n           radical prostatectomy\n\n        -  outcome assessment: accuracy of PET/MR for localization and staging of prostate cancer\n           compared with MRI only and PET/CT only\n\n      To establish the imaging biomarker using PET/MR for early detection of recurrent prostate\n      cancer\n\n        -  Recruiting 15 patients with recurrent prostate cancer treated by surgery, hormone, or\n           radiation therapy\n\n        -  Recruiting 15 patients with treated prostate cancer without recurrence\n\n        -  PET/MR using 18F-choline with dedicated prostate MRI in all patients\n\n        -  PET/MR using 18F-FDG in all patients after 2-7 days\n\n        -  PET/CT using 18F-FDG in all patient immediate after 18F-FDG PET/MR\n\n        -  comparison of findings on PET/MR, MRI, and PET/CT with clinical data in two patient\n           groups with or without recurrent prostate cancer\n\n        -  outcome assessment: accuracy of PET/MR for early detection and localization of\n           recurrent prostate cancer compared with MRI only and PET/CT only"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patient with prostate cancer before treatment\n\n          -  patient with prostate cancer treated\n\n          -  patient with prostate cancer recurrent\n\n        Exclusion Criteria:\n\n          -  patient with contraindication for MRI\n\n          -  Patient with severe renal impairment"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01938339", 
            "org_study_id": "PETMR-Prostate"
        }, 
        "intervention": {
            "arm_group_label": "PET/MR", 
            "description": "Multi-radiotracer PET/MR will be performed in patients with primary and recurrent prostate cancer", 
            "intervention_name": "PET/MR", 
            "intervention_type": "Device", 
            "other_name": "Biograph mMR, Siemens Healthcare"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "prostate cancer", 
            "MRI", 
            "PET"
        ], 
        "lastchanged_date": "December 3, 2013", 
        "location": {
            "contact": {
                "email": "onara53@naver.com", 
                "last_name": "Hyeon Jin Kim, RN", 
                "phone": "82-10-9944-2569"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Jin Chul Paeng, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Gi Jeong Cheon, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Cheol Kwak, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "1", 
        "official_title": "Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer", 
        "overall_contact": {
            "email": "radjycho@snu.ac.kr", 
            "last_name": "Jeong Yeon Cho, MD", 
            "phone": "82-2-2072-3074"
        }, 
        "overall_contact_backup": {
            "email": "iwishluv@empas.com", 
            "last_name": "Sang Youn Kim, MD", 
            "phone": "82-2-2072-3321"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Jeong Yeon Cho, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "analysis of accuracy of PET/MR predicting localization and staging of prostate cancer by comparison of PET/MR findings with pathological mapping images after radical prostatectomy", 
            "measure": "accuracy of PET/MR predicting localization and staging of prostate cancer", 
            "safety_issue": "No", 
            "time_frame": "1 week after radical prostatectomy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01938339"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "accuracy of PET/MR for early detection and localization of recurrence by comparison of PET/MR findings with clinical data in two groups of patients with or without recurrent prostate cancer", 
            "measure": "accuracy of early detection and localization of recurrent prostate cancer", 
            "safety_issue": "No", 
            "time_frame": "1 week after PET/MR imaging"
        }, 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}